B Alert

Researchers explore the dangers of hepatitis B and HIV coinfection by Larry Buhl New research suggests people with chronic hepatitis B virus (HBV) infection have twice...

Care Costs

LifeGuide New HCV Meds Are on the Horizon, but Affordability May Still Remain a Challenge by Larry Buhl This column has covered several antiviral meds in...

The Early Days

LifeGuide Dr. C. Everett Koop Revisits a Time When Neither Treatment nor Testing Existed by Chael Needle Knowing he had to face the micromanaging tendencies and...

Old Concept, New Hope

LifeGuide Therapeutic Vaccines May Change the Treatment Landscape for the Better by Jeannie Gibbs Clinical development of HIV therapeutic vaccine candidate, Vacc-4x, will continue after further...

Dos & Dont’s

Hep C Is Manageable—If You Know the Ins and Outs by Larry Buhl You’ve been diagnosed with Hepatitis C. Now what? First, don’t panic. Doctors agree...

Going Viral

While federal efforts move forward, hepatitis prevention remains unfunded by Larry Buhl During the seemingly interminable debate over health insurance reform, other health legislation was quietly...

Fat Chance

A Treatment for Lipodystrophy-Related Excessive Abdominal Fat Comes of Age by Chael Needle HIV-associated lipodystrophy, abnormalities in metabolism and/or distribution of fat in those living with...

Be Smart

In an Effort to Prevent HCV, One Campaign Is Educating Youth on Body Art Risks by Larry Buhl In the U.S., an estimated thirty-six percent of...

Borrowing Therapies

Two Anti-Cancer Drugs Are Tapped in the Fight Against HIV by Chael Needle New types of drugs are needed in the fight against HIV but some of...

Clearing Hurdles

What can we do to address the obstacles to HCV treatment? by Larry Buhl Hepatitis C (HCV) is a “silent killer” in more ways than one....

LATEST POSTS

POZIAM: Hank Trout

Recently POZIAM spoke with Hank Trout about living with HIV and advocating as a long-term survivor. Hank Trout is an Editor at Large for...

A Letter to Myself at 18